Table 2 Selected results from the screening (homo- and hetero-
combinations) of phosphites (2a–d) and C1-symmetric phosphinamines
(4b–e) in the palladium-catalysed asymmetric allylic substitution of
rac-1,3-diphenyl-3-acetoxyprop-1-ene with dimethyl malonatea
Scheme 1 Rhodium-catalysed asymmetric hydrogenation of methyl
2-acetamidoacrylate and N-(1-phenylvinyl)acetamide.
Entry
Ligands
Conv. (%)
e.e. (%) (R,S)
Homocombinations
1
2
3
(R)-2b
(R)-4b
(S)-4b
100
100
100
58 (S)
68 (R)
68 (S)
Table 1 Selected results from the screening (homo- and hetero-
combinations) of phosphites (2a–d) and C1-symmetric phosphin-
amines (4b–e) in the rhodium-catalysed asymmetric hydrogenation
of methyl 2-acetamidoacrylate and N-(1-phenylvinyl)acetamidea
Heterocombinations
4
5
(R)-2b/(R)-4b
(R)-2b/(S)-4b
100
100
69 (S)
69 (S)
a
Entry
R
Ligands
Conv. (%)
e.e. (%) (R,S)
Reaction conditions: ligand (0.0311 mmol) or mixture of ligands
(0.0155 mmol each), [Pd(allyl)Cl]2 (0.0077 mmol), rac-1,3-diphenyl-3-
acetoxyprop-1-ene (0.51 mmol), dimethyl malonate (1.5 mmol),
N,O-bis(trimethylsilyl)acetamide (BSA) (1.5 mmol), a pinch of AcOK,
Homocombinations
1
2
3
4
5
6
COOMe
COOMe
COOMe
Ph
Ph
Ph
(R)-2b
(R)-4b
(S)-4b
(R)-2b
(R)-4b
(S)-4b
100
52
57
100
83
74
96 (S)
12 (S)
12 (R)
92 (S)
7 (R)
1
CH2Cl2 (2.0 ml), RT, 1 h. Conversions were determined by H-NMR
analysis of the crude reaction mixtures, while e.e.’s were determined
by HPLC equipped with a chiral column (CHIRALCEL OD-H,
hexane–isopropanol 99 : 1, flow rate 0.3 ml minꢀ1, 250 nm, see
the ESIz).
7 (S)
Heterocombinations
7
8
9
10
COOMe
COOMe
Ph
(R)-2b/(R)-4b
(R)-2b/(S)-4b
(R)-2b/(R)-4b
(R)-2b/(S)-4b
87
48
99
96
60 (R)
40 (R)
57 (R)
38 (R)
Ph
generates heteroleptic catalysts in Rh- and Pd-mediated
reactions.
a
Reaction conditions: ligand (0.0154 mmol) or mixture of ligands
(0.0077 mmol each), Rh(COD)2BF4 (0.007 mmol), substrate
(0.7 mmol), CH2Cl2 (8.0 ml), RT, 16 h. Substrate = methyl 2-acetamido-
acrylate: H2 (1 bar); Substrate = N-(1-phenylvinyl)acetamide: H2 (5 bar).
Conversions and e.e.’s were determined by GC equipped with a chiral
capillary column (MEGADEX DACTBSb, diacetyl-t-butylsilyl-b-cyclo-
dextrin, see the ESIz).
We thank the European Commission [RTN Network
(R)Evolutionary Catalysis MRTN-CT-2006-035866] for
financial support and for predoctoral fellowships (to B. Lynikaite
and M. Krupicka). L. Pignataro gratefully acknowledges
the Universita degli Studi dell’Insubria for a postdoctoral
fellowship (assegno di ricerca).
Notes and references
enantioselectivity in the hydrogenation of methyl 2-acetamido-
acrylate (60% e.e., R, entry 7), compared to both the
phosphite (96% e.e., S, entry 1) and the phosphinamine alone
(12% e.e., S, entry 2)! A similar behaviour was also
observed in the hydrogenation of N-(1-phenylvinyl)acetamide
(cf. entries 4–6 and 9–10). This is clearly the sign
that a heteroleptic catalyst is active in the hydrogenation
reaction.
Unfortunately, contrary to the literature precedents9 and
our own expectations, in these reactions the heteroleptic
catalyst induced a lower rate and a diminished enantiomeric
excess compared to the phosphite homocomplex.
1 M. T. Reetz and G. Mehler, Angew. Chem., Int. Ed., 2000, 39,
3889.
2 (a) M. T. Reetz and T. Sell, Tetrahedron Lett., 2000, 41, 6333;
(b) C. Claver, E. Fernandez, A. Gillon, K. Heslop, D. J. Hyett,
A. Martorell, A. G. Orpen and P. G. Pringle, Chem. Commun.,
2000, 961.
3 M. van den Berg, A. J. Minnaard, E. P. Schudde, J. Van Esch, A.
H. M. de Vries, J. G. de Vries and B. L. Feringa, J. Am. Chem.
Soc., 2000, 122, 11539.
4 L. Palais, I. S. Mikhel, C. Bournaud, L. Micouin, C. A. Falciola,
M. Vuagnoux-d’Augustin, S. Rosset, G. Bernardinelli and
A. Alexakis, Angew. Chem., Int. Ed., 2007, 46, 7462.
5 T. Jerphagnon, J.-L. Renaud and C. Bruneau, Tetrahedron:
Asymmetry, 2004, 15, 2101, and references therein.
6 (a) J. G. De Vries and L. Lefort, Chem.–Eur. J., 2006, 12, 4722, and
The 1 : 1 combination of binol-derived phosphite (R)-2b and
phosphinamine (R)-4b induced a peculiar stereochemical
outcome also in the palladium-catalysed asymmetric allylic
substitution of rac-1,3-diphenyl-3-acetoxyprop-1-ene with
dimethyl malonate12 (Scheme 2, Table 2, 69% e.e., S, entry 4),
compared to both the phosphite (58% e.e., S, entry 1) and the
phosphinamine alone (68% e.e., R, entry 2).
references therein; (b) C. Jakel and R. Paciello, Chem. Rev., 2006,
106, 2912.
¨
7 (a) M. T. Reetz, T. Sell, A. Meiswinkel and G. Mehler, patent
application DE20021047633 (application date 11 October 2002);
(b) M. T. Reetz, T. Sell, A. Meiswinkel and G. Mehler, Angew.
Chem., Int. Ed., 2003, 42, 790; (c) M. T. Reetz and G. Mehler,
Tetrahedron Lett., 2003, 44, 4593.
8 (a) D. Pena, A. J. Minnaard, J. A. F. Boogers, A. H. M. de Vries,
J. G. de Vries and B. L. Feringa, Org. Biomol. Chem., 2003, 1,
1087; (b) A. Duursma, R. Hoen, J. Schuppan, R. Hulst,
A. J. Minnaard and B. L. Feringa, Org. Lett., 2003, 5, 3111.
9 M. T. Reetz, Angew. Chem., Int. Ed., 2008, 47, 2556, and references
therein.
In summary, we have shown that the binaphthol-derived
phosphite : C1-symmetric phosphinamine ligand combination
10 P.-A. R. Breuil, F. W. Patureau and J. N. H. Reek, Angew. Chem.,
Int. Ed., 2009, 48, 2162.
11 A. D. Becke, J. Chem. Phys., 1993, 98, 5648.
12 (a) M. Dieguez, O. Pamies and C. Claver, J. Org. Chem., 2005, 70,
´
3363; (b) S. Deerenberg, H. S. Schrekker, G. P. F. van Strijdonck,
P. C. J. Kamer, P. W. N. M. van Leeuwen, J. Fraanje and
K. Goubitz, J. Org. Chem., 2000, 65, 4810.
Scheme 2 Palladium-catalysed asymmetric allylic substitution of
rac-1,3-diphenyl-3-acetoxyprop-1-ene with dimethyl malonate.
ꢁc
This journal is The Royal Society of Chemistry 2009
Chem. Commun., 2009, 3539–3541 | 3541